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Abstract
CONSULT is a decision-support framework designed to
help patients self-manage chronic conditions and adhere to
agreed-upon treatment plans, in collaboration with health-
care professionals. The approach taken employs computa-
tional argumentation, a logic-based methodology that pro-
vides a formal means for reasoning with evidence by sub-
stantiating claims for and against particular conclusions. This
paper outlines the architecture of CONSULT, illustrating how
facts are gathered about the patient and various preferences of
the patient and the clinician(s) involved. A logic-based rep-
resentation of official treatment guidelines by various pub-
lic health agencies is presented. Logical arguments are con-
structed from these facts and guidelines; these arguments are
analysed to resolve inconsistencies concerning various treat-
ment options and patient/clinician preferences. The claims
of the justified arguments are the decisions recommended by
CONSULT. A clinical example is presented which illustrates
the use of CONSULT within the context of blood pressure
management for secondary stroke prevention.
1 Introduction
Many countries, such as the United Kingdom (UK), have
growing populations and comprehensive healthcare systems.
Modern improvements in medical diagnosis mean that more
people living with multiple chronic morbidities are aware
of their conditions. These conditions require constant man-
agement by clinicians and thus consume considerable public
health resources (Guzman-Castillo et al. 2017). Patients who
self-manage their conditions take pressure off public health
resources and experience long-term health benefits (Tatter-
sall 2002). As technology has advanced, smartphone and
wellness sensor technologies are now capable of recording
personal health and activity data that may be relevant for
self-management, for example, wellbeing determination in
the elderly (Suryadevara and Mukhopadhyay 2012). How-
ever, such data may be noisy, and alternative treatment plans
can be conflicting. Both patients and clinicians will need to
select amongst various treatment plans while also consider-
ing issues such as the side effects of drugs, personal treat-
ment preferences and lifestyle constraints.
Copyright c© 2018, Association for the Advancement of Artificial
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The Collaborative Mobile Decision Support for Manag-
ing Multiple Morbidities project1 seeks to design, verify
and implement CONSULT, a framework that will gather
data from wellness sensors, a patient’s own electronic health
record (EHR), official clinical guidelines, and input from the
patient and their team of carers. CONSULT will then use
computational argumentation to reason with this data, and
so justify potential courses of action.
Computational argumentation (Rahwan and Simari
2009), a well-founded logic methodology with roots in phi-
losophy, has been applied in artificial intelligence (AI) and
multi-agent systems as a structured technique for reasoning
in which conclusions are drawn from evidence that supports
the conclusions. The amenability and the transparency of
computational argumentation to human understanding have
led to its extensive application in medical decision sup-
port systems (Glasspool et al. 2006). As a proof-of-concept,
CONSULT focuses on the use case of secondary stroke pre-
vention in recovering stroke patients, an important aspect
of which is through managing of the patient’s blood pres-
sure (BP). CONSULT aims to support stroke patients in self-
managing their BP, with periodic feedback from clinicians.
The reasoning processes articulated in this paper will form a
key part towards achieving CONSULT’s goals.
Consider Example 1 where a treatment should be offered
to a recovering stroke patient. In this paper, we aim to for-
mally represent the knowledge in case studies such as the
one in Example 1, and reason with it in order to justify pos-
sible treatment plans.
Example 1. Eric is a 52-year-old male who had just suf-
fered a stroke. He is overweight and has hypertension. When
Eric sees his general practitioner (GP), their aim is to pre-
vent Eric from suffering another stroke. It is therefore crucial
to keep Eric’s BP under control. However, there are several
treatment options for the GP to consider, with choice depen-
dent on the priorities of the GP and patient, which may not
be aligned. Here, Eric prefers lifestyle changes over drugs
but the GP prefers prescribing a drug.
The contributions of this paper are as follows: (i) We pro-
pose a logic-based representation of official treatment guide-
lines relevant to the treatment of hypertension, (ii) We con-
struct arguments for various treatment options by introduc-
1UK EPSRC grant EP/P010105/1, 2017–2020.
ing a new argument scheme with associated critical ques-
tions, (iii) We use extended argumentation frameworks to
provide concrete arguments recommending possible courses
of treatment given patient data and preferences of both pa-
tient and clinician(s).
The outline of this paper is as follows: Section 2 pro-
vides background on computational argumentation and ar-
gument schemes. In Section 3, we outline the architecture
of the CONSULT framework. In Section 4, we illustrate and
demonstrate the applicability of our approach on Example 1.
In Section 5, we briefly discuss related work. Section 6 high-
lights directions for future research, such as the treatment
of other conditions, multiple-morbidities and polypharmacy,
and the data-driven aspects of wellness sensors, in addition
to some further challenges for the application of argumenta-
tion theory to the medical domain.
2 Background
In this section, we provide an overview of key concepts
in computational argumentation (hereafter “argumentation”)
theory that are relevant to reasoning about courses of treat-
ment and their possible side effects, given facts about the pa-
tient and preferences of the patient and clinicians involved.
Abstract and Extended Argumentation Theory
Argumentation theory is a branch of AI that studies reason-
ing with incomplete and conflicting information, one appli-
cation of which is in the field of medical decision support
systems. Our starting point is Dung’s abstract argumenta-
tion theory (Dung 1995). Arguments are represented with
a directed graph 〈Arg,R〉 called an (abstract) argumenta-
tion framework (AF), whereArg is the set of arguments and
R ⊆ Arg2 is the binary attack relation such that for argu-
ments A and B, (A,B) ∈ R iff A attacks (i.e., is a counter-
argument to) B. Let S ⊆ Arg be a set of arguments. We say
S is conflict-free (cf) iff S2∩R= ∅; i.e., no two arguments
in S attack each other. We say an argument A ∈ Arg is ac-
ceptable w.r.t. S iff all attackers of A are in turn attacked
by some argument in S. For any S let d(S) ⊆ Arg denote
the set of arguments acceptable w.r.t. S. We say S is self-
defending (sd) iff S ⊆ d(S). We say S is admissible iff it
is cf and sd. Intuitively, admissible sets of arguments repre-
sent justified sets of arguments that are collectively consis-
tent and can respond to all counter-arguments. Since safety
is often paramount in medical decision support (Tolchinsky
et al. 2012), we use the grounded extension, defined to be the
⊆-smallest admissible set satisfying S = d(S), which al-
ways exists and is unique; this captures a conservative form
of reasoning where justified arguments are grounded upon
incontrovertible truths and are easily computed. Assume that
the following dialogue occurs between Eric and his GP:
• GP: “Your test results indicate that you have previously
had a mini-stroke.” (Argument A)
• Eric: “Actually, I don’t feel like I had a mini-stroke, there-
fore I did not have a mini-stroke.” (Argument B)
Abstract argumentation would formalise this as Arg =
{A,B} and R = {(A,B), (B,A)} because Eric and his
GP disagree. Both {A} and {B} are admissible sets. How-
ever, the grounded extension is ∅, so neither {A} nor {B}
is justified. In other words, no recommendation can be made
unless we take into account preferences.
Extended argumentation frameworks (EAFs) (Modgil
2009) were developed to enable reasoning about prefer-
ences over arguments by incorporating arguments that claim
preferences over other arguments. Formally, an EAF is a
structure 〈Arg,R,D〉 where 〈Arg,R〉 is an AF and D ⊆
Arg × R is the meta-attack relation. If (X, (A,B)) ∈ D
then this denotes that X ∈ Arg attacks the attack from A to
B by claiming that B is preferred to A, so X would invali-
date this attack. Whenever two argumentsX andX ′ express
contrary preferences, they would symmetrically attack each
other. Formally, if (X, (A,B)) and (X ′, (B,A)) ∈ D then
(X,X ′) and (X ′, X) ∈ R. The notion of admissible sets
can be appropriately generalised to EAFs, but for our pur-
poses, arguments that are not attacked are justified, while
arguments that are attacked by justified arguments cannot
be justified. Attacks that are meta-attacked by justified argu-
ments are rendered ineffective.
If we assume that the GP’s argument (Argument A) is
stronger or preferred to Eric’s argument (Argument B), then
we can represent this as a preference argument (Argument
C), claiming that A is preferred to B. We represent this by
a meta-attack relation D={(C, (B,A))}. {B} is no longer
justified since C is attacking the attack (B,A), hence A is
justified and the grounded extension is {A,C}.
Argument Schemes and Critical Questions
In practical reasoning, arguments can be challenged and de-
feated by further arguments. It is therefore possible to iden-
tify more arguments and consider alternatives, if any. Intu-
itively, arguments should first be challenged, then become
justified and taken into consideration if they survive being
defeated. One way of doing this is using argument schemes
and critical questions.
Argument schemes (Walton, Reed, and Macagno 2008)
are semi-formal representations of the structures of common
types of arguments. One of the key features of argument
schemes is the list of associated critical questions (CQs).
The claim that a scheme supports is presumptive and the
claim is withdrawn unless the CQs posed have been an-
swered successfully. The instantiation of the appropriate ar-
gument scheme, in conjunction with its associated CQs is
a method of generating a set of arguments. The inference
mechanism characterized by the argument scheme will en-
sure that only arguments that have not been defeated by the
CQs will be generated.
Table 1 shows Walton’s Sufficient Condition Scheme for
practical reasoning. This scheme states that an agent should
perform an action if this action helps that agent to achieve
its goal. Walton proposes four CQs: (1) Are there alternative
ways of realising goal G?, (2) Is it possible to do action A?,
(3) Does agent a have goals other than G which should be
taken into account?, and (4) Are there other consequences of
doing action A which should be taken into account? These
questions can serve as counterarguments for arguments that
conform to the Sufficient Condition Scheme. For example,
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Figure 1: The architecture of the knowledge bases, databases and argument schemes used by CONSULT
according to the first CQ, if there are alternative ways of car-
rying out the same goal, then these alternatives may change
the outcome of the decision process of the agent.
AS
G is a goal for agent a
Doing action A is sufficient for a to carry out goal G
Therefore agent a ought to do action A.
Table 1: Walton’s Sufficient Condition Scheme
3 CONSULT
In this section, we outline the CONSULT framework and
explain its various components. Figure 1 illustrates the ar-
chitecture of CONSULT, enumerating the knowledge bases
(KB) and databases (DB) considered and showing how as-
pects of argumentation come into play. We distinguish a
knowledge base, a set of rules, from a database, a set of facts
or data points.
When prescribing a treatment plan for a patient, GPs in
the UK follow the National Institute for Health and Care
Excellence (NICE) guidelines for treatment options, while
also taking into account patient-specific data, treatment costs
and patient / clinician preferences.
The CONSULT framework aims to support this process
by identifying arguments that justify various treatment op-
tions specific to the patient. It includes a Patient Database
(DB), which contains all available data and facts about each
patient. Its NICE Knowledge Base (KB) represents the most
relevant clinical guidelines for treating the patient. CON-
SULT constructs arguments for and against various treat-
ments specific to a patient with its Treatment Engine, which
uses argument schemes that are subjected to CQs. One of
the CQs leverages the Cost Engine to ensure that any treat-
ment cost considerations are applied, hence arguments for
equally effective but more expensive treatments will be de-
feated. The arguments not defeated by the CQs will form an
AF. One aim is for CONSULT to be able to reason with and
about GP and patient preferences through the use of EAFs.
Step (1.a):
“Offer people aged under 55 years step 1 antihyper-
tensive treatment with an ACE inhibitor or a low-cost
ARB.
If an ACE inhibitor is prescribed and is not tolerated
(for example, because of cough), offer a low-cost ARB.
Beta-blockers are not a preferred initial therapy for hy-
pertension. However, beta-blockers may be considered
in younger people, particularly: (1) those with an in-
tolerance or contraindication to ACE inhibitors and
angiotensin II receptor antagonists, or (2) women of
child-bearing potential, or (3) people with evidence of
increased sympathetic drive.”
Step (1.b):
“Offer step 1 antihypertensive treatment with a CCB
to people aged over 55 years and to black people of
African or Caribbean family origin of any age.
If a CCB is not suitable, for example because of oedema
or intolerance, or if there is evidence of heart failure
or a high risk of heart failure, offer a thiazide-like di-
uretic.”
Table 2: Step 1 of NICE guideline CG127
Knowledge Representation for the Treatment of
Hypertension
In order for CONSULT to reason about treatment plans,
we represent knowledge in the hypertension domain using
first order logic. For example, we represent the hypertension
treatment guideline CG127 published by NICE (NICE 2016)
(see Table 2). Patient characteristics, such as ethnicity or ex-
perienced side effects could change the treatment plan. We
then represent the treatment options for hypertension by fol-
lowing the patient information leaflet provided by the UK’s
National Health Service (NHS) Choices.
Representation of the Relevant NICE Guideline NICE
has a set of guidelines to help healthcare professionals in
diagnosing and treating primary hypertension, and thereby
reducing the risk of primary and secondary strokes. The
guideline CG127 mentions four types of drugs: A, B, C and
D. A refers to ACE Inhibitor or low-cost Angiotensin II re-
ceptor blocker (ARB), B refers to Beta-blocker, C refers to
calcium-channel blocker (CCB) and D refers to thiazide-like
Diuretic. The guideline includes treatment steps, such that a
patient progresses to the next step and takes a new drug if
their BP does not improve in the previous step. The guide-
line provides guidance on which of the treatments or treat-
ment combinations should be considered at each step.
Step (1.a):
(age<55)→ offer(A1, S1, d) ∨ offer(A2, S1, d)
¬tolerated(A1)→ offer(A2, S1, d) ∧ ¬offer(A1, S1, d)
¬tolerated(A2)→¬offer(A2, S1, d)
¬tolerated(A1) ∨ ¬tolerated(A2)→ offer(B, S1, d)
chbearing-potential∨inc-sympa-drive→ offer(B, S1, d)
Step (1.b):
(age≥55) ∨ bl-afr ∨ bl-car→ offer(C, S1, d)
¬tolerated(C)→¬offer(C, S1, d) ∧ offer(D, S1, d)
oedema∨heart-failure∨hr-heart-failure→ offer(D, S1, d)
All Steps:
→ offer(LS, Y, -)
offer(A1, Y, d)→¬offer(A2, Y, d)
offer(A2, Y, d)→¬offer(A1, Y, d)
offer(X, Y, high-dose)→¬offer(X, Y, low-dose)
offer(X, Y, low-dose)→¬offer(X, Y, high-dose)
Table 3: Step 1 anti-hypertensive treatment as logic rules
To represent CG127 formally, we denote each treatment
step as Si, which represents the i-th step in the treatment
plan. Table 2 is the guideline for S1. Let A1 denote ACE In-
hibitor and A2 denote ARB. We formally represent this in-
formation using the logic rules shown in Table 3. The other
treatment steps are represented formally in the same manner.
The guideline and the rules of these steps are shown in Ta-
bles 4 and 5, respectively. Note that, for simplicity, we only
represent part of the NICE guideline. For example, we do
not indicate either thiazide-like diuretic names (e.g., chlor-
talidone) or drug dosages (e.g., 12.5−25.0 mg once daily).
Each rule is of the form P → Q, which means that if
the antecedent P holds, then the consequent Q also holds.
Both P and Q can consist of disjunctions (∨) and con-
junctions (∧) of atoms. The atoms are the facts about the
patient (e.g., Black-African). During the treatment, the GP
can decide to use different doses of a drug such as the
maximally tolerated dose (high-dose) or the minimal effec-
tive dose (low-dose). The atom offer(X,Y, d) states that
the drug X ∈ {A1, A2, B, C,D, αB} (where αB denotes
alpha-blocker) should be prescribed in Step Y ∈ {Si}4i=1
with dose d (high-dose or low-dose). For example, in Step
(1.a), a white male patient aged 40 who is intolerant to A1
can be offered low-dose A2 or B.
The NICE guideline points out that under some condi-
Step 2:
“If blood pressure is not controlled by step 1 treatment,
offer step 2 treatment with a CCB in combination with
either an ACE inhibitor or an ARB.
If a CCB is not suitable for step 2 treatment, for ex-
ample because of oedema or intolerance, or if there is
evidence of heart failure or a high risk of heart failure,
offer a thiazide-like diuretic.
For black people of African or Caribbean family origin,
consider an ARB in preference to an ACE inhibitor, in
combination with a CCB.
If therapy is initiated with a beta-blocker and a second
drug is required, add a CCB rather than a thiazide-like
diuretic to reduce the person’s risk of developing dia-
betes.”
Step 3:
“If treatment with three drugs is required, the combi-
nation of ACE inhibitor or ARB, CCB and thiazide-like
diuretic should be used.”
Step 4:
“Consider further diuretic therapy.
If further diuretic therapy for resistant hypertension at
step 4 is not tolerated, or is contraindicated or ineffec-
tive, consider an alpha- or beta-blocker.”
Table 4: Steps 2-4 of NICE guideline CG127
tions, it is better to choose one treatment over another. For
example, if a patient uses a beta-blocker (B) in his therapy
and a second drug is required, then it is better to offer CCB
(C) to reduce the patient’s risk of developing diabetes (Step
2 in Table 4). We represent such preferences by the atom
pref (Y, Z), where Y and Z are possible treatment options,
which states that Z is a more preferred treatment than Y . For
example:
pref (offer(D,S2, d), offer(C, S2, d))
represents such a preference from the NICE guideline.
For all of the treatment steps in the NICE guideline, A1
and A2 cannot be used together, and a treatment can only
be used in a single dose (either a low-dose or a high-dose).
These restrictions are also defined as logic rules, as shown
at the bottom of Table 3. Moreover, the GP has the option to
treat hypertension with lifestyle changes (e.g., losing weight,
eating a healthy diet and exercise); we represent such treat-
ment options as LS. In future work, CONSULT will be able
to monitor a patient’s actual lifestyle changes; e.g., through
wellness sensor measurements of daily activity and weight.
Representation of the NHS Choices Leaflet Each treat-
ment requires use of drugs that may result in negative side
effects. In such cases, healthcare professionals may try alter-
native treatments. In Table 6, we show how observing vari-
ous side effects affects treatment options (NHS 2016), rep-
resented as rules in first order logic. For example, if there
Step 2:
offer(A1, S1, d) ∨ offer(A2, S1, d)→ offer(C, S2, d)
offer(C, S1, d)→ offer(A1, S2, d) ∨ offer(A2, S2, d)
¬tolerated(C)→¬offer(C, S2, d) ∧ offer(D, S2, d)
oedema∨heart-failure∨hr-heart-failure→ offer(D, S2, d)
bl-afr ∨ bl-car→ offer(A1, S2, d) ∨ offer(A2, S2, d)
bl-afr ∨ bl-car→ pref(offer(A1, S2, d), offer(A2, S2, d))
offer(B, S1, d)→ offer(C, S2, d) ∨ offer(D, S2, d)
offer(B, S1, d)→ pref(offer(D, S2, d), offer(C, S2, d))
Step 3:
→ offer(D, S3, d)
Step 4:
→ offer(D, S4, d)
¬tolerated(D)→ offer(αB, S4, d) ∨ offer(B, S4, d)
Table 5: Steps 2-4 anti-hypertensive treatment as logic rules
is evidence of flu-like symptoms, then the GP can prescribe
A2 instead of A1 during the treatment process.
pregnancy ∨ breastfeeding→
¬offer(A1, S, d) ∧ ¬offer(A2, S, d) ∧ ¬offer(D, S, d)
dry-cough ∨ dizziness ∨ headaches ∨ rash→
¬offer(A1, S, d)
dizziness ∨ headaches ∨ flu-like-symptoms→
¬offer(A2, S, d)
headaches ∨ swollen-ankles ∨ constipation→
¬offer(C, S, d)
dizziness ∨ increased-thirst ∨ increased-toilet-frequency
∨ rash→¬offer(D, S, d)
erectile-dysfunction ∨ fall-in-potassium-levels→
¬offer(D, S, d)
dizziness ∨ headaches ∨ tiredness ∨ cold-hands-feet→
¬offer(B, S, d)
dizziness ∨ light-headedness ∨ fainting→
¬offer(αB, S, d)
Table 6: Anti-hypertensive Treatment Options as defined by
NHS. S is the current treatment step for the patient.
Argument Scheme for Proposed Treatment
In order to generate arguments in support of different treat-
ment options, we use an argument scheme structure simi-
lar to the practical reasoning scheme (Walton, Reed, and
Macagno 2008). Our argument scheme generates an argu-
ment in support of each possible treatment, given the known
Facts F about the patient and the treatment goal G to be
realised, e.g., lowering the patient’s BP. The arguments in-
stantiated by this scheme are all subject to CQs. In this case
the critical questions are used to generate counterarguments
to the arguments instantiated by the AS. These counterar-
guments will be generated when a treatment has either been
used before unsuccessfully or has caused side effects, as well
when an equivalent cheaper treatment is possible.
In Table 7, we propose an argument scheme – the argu-
ment scheme for a Proposed Treatment (ASPT). The pa-
tient facts F include their age, BP (including stage), ethnic-
ity, previous treatments and the current treatment step. The
Treatment Engine reasons with the patient facts to find pos-
sible treatments from the NICE KB. Note that each possible
treatment conforms to the ASPT.
ASPT
premise - Given the patient Facts F
premise - In order to realise the goal G
premise - Treatment T promotes the goal G
therefore : Treatment T should be considered
Table 7: Argument scheme for a proposed treatment
Critical Questions. Arguments instantiating the scheme
will be subject to the following CQs:
CQ 1. Has this treatment been unsuccessfully used on the
patient in the past?
CQ 2. Has the patient experienced side effects from this
treatment in the past?
CQ 3. Is there an equivalent cheaper treatment for the treat-
ment step of the patient?
If ASPT yields an argument in support of treatment T ,
then the CQs have the potential to attack or yield additional
arguments for possible treatments. For example, if the Cost
Engine indicates an equivalent cheaper treatment, then CQ3
yields a counter-argument proposing this treatment.
The resulting set of arguments will form an AF. An exam-
ple is illustrated in Figure 2, where the argument framework
(AF) consists of three arguments and four attacks between
arguments. We will explore this AF in more detail in the
next section.
th1
tl1tls
Figure 2: The Argument Framework for Example 1
Reasoning with Preferences
There are differing orders of preferences over the possible
treatments for a patient, namely ones from the GP (who may
prefer the most effective treatment) and ones from the pa-
tient (who may prefer to minimise side effects). There may
also be additional preference orders from external sources
such as secondary care specialists, other GPs or the patient’s
family members who are involved in managing their care.
In order to derive the meta-level arguments, these prefer-
ence orders over treatments need to be expressed as attacks
over the attacks between arguments in support of treatments.
For example, if we have the expressed preference between
the treatments x and y such that x  y when x is strictly
more preferred, then this can be represented as an argument
(i, (y, x)) where i denotes the argument for preferring x to
y. Intuitively, if x is preferred to y, then the preference argu-
ment i attacks the attack from y to x, as y is less preferred.
The meta-level arguments expressing the preference or-
ders will form part of the EAF. Different sets of preferences
can be considered simultaneously in an EAF by deciding a
priority between the different preference orders. A treatment
argument is justified if it is part of the grounded extension
of the EAF.
4 Execution of the Running Example
We now return to our sample patient scenario to illustrate our
system, introduced in Example 1. The facts about Eric from
the Patient DB are formally represented as follows: feric =
{age=52, ethnicity=white, overweight}. Eric has never been
prescribed medication for hypertension before, as such he is
in step one (S1) and should be offered only one treatment.
By instantiating the argument scheme ASPT, as shown in
Table 8, the Treatment Engine generates arguments each in
support of one of five treatments that are shown in Table 9.
ASPT(Eric, ti)
premise - Given the patient facts feric
premise - In order to realise the goal G
premise - Treatment ti promotes the goal G
therefore : Treatment ti should be considered
Table 8: Instantiating ASPT for Eric per treatment
However, these arguments for possible treatments are sub-
ject to CQs, as follows. As Eric has not been prescribed any
BP medication in the past, he did not experience any side
effects from such a treatment (CQ 2) and no BP treatments
are known to have been been unsuccessful for Eric (CQ 1).
Only CQ 3 instantiates counter-arguments in Example 1: tl2
and th2 are more expensive but their treatment outcomes are
equivalent to tl1 and t
h
1 , respectively. This information is pro-
vided by the Cost Engine. Accordingly, tl2 and t
h
2 are de-
feated since there are cheaper treatment options. The set of
arguments in support of possible treatments is reduced to
three arguments (tls, tl1 and t
h
1 ), each in support of a differ-
ent treatment. These arguments are added to the AF since
they conform to the CQs (CQ 1, CQ 2 and CQ 3).
Figure 2 depicts the current AF. Each argument in support
of a treatment is represented as a node. The arrows denote
the attacks between the arguments. Argument tl1 and t
h
1 are
attacking each other as these treatments cannot be offered
together (Table 3). Eric views tls as an alternative treatment,
which is mutually exclusive to both th1 and t
l
1; hence there
are asymmetric attacks between tls and the other treatment
arguments in the AF.
A treatment should be chosen by considering the prefer-
ences over treatments. In Example 1, there are two sets of
preferences: the patient’s (Eric) and the GP’s. Eric prefers
tls: offer(LS, S1, -)
tl1: offer(A1, S1, low-dose)
th1 : offer(A1, S1, high-dose)
tl2: offer(A2, S1, low-dose)
th2 : offer(A2, S1, high-dose)
Table 9: Possible Treatments for Eric as recommended by
the Treatment Engine
making lifestyle changes; i.e., tls  th1 and tls  tl1. The GP
prefers prescribing some drug; i.e., tls ≺ th1 and tls ≺ tl1,
and the GP may prefer to treat with the higher tolerated dose;
i.e., th1  tl1. The meta-level arguments are derived from the
preference relations as follows:
• For Eric: {(el, (tl1, tls)), (eh, (th1 , tls))}
• For the GP: {(gh, (tls, th1 )), (gl, (tls, tl1)), (gd, (tl1, th1 ))}
The preference orders resulting from Eric’s and the GP’s
preferences are also in direct conflict, therefore there are ad-
ditional attacks between these. These are illustrated in the
EAFs in Figure 3, where each EAF displays different prece-
dences between the preferences of Eric and the preferences
of the GP.
Figure 3a illustrates the EAF resulting from Eric’s pref-
erences taking precedence. The grounded extension in this
EAF is {tls, gd, eh, el, (ehgh), (elgl)}. Hence, the only
treatment argument in the grounded extension is tls. In Fig-
ure 3b, the GP’s preferences take precedence over Eric’s. In
the resulting EAF, the grounded extension is {th1 , tls, gd, gl,
(gheh), (glel), gh}. This set contains both th1 and tls, so
these two treatments are justified in this setting.
Should the GP want to explicitly exclude lifestyle changes
from the set of possible treatments, then this would be
achieved by an argument ¬tls that would attack tls. This
could be a relevant option if the patient’s physical condition
would not allow sufficient changes to affect BP.
5 Related Work
Over the last few decades, argumentation theory has been
applied to a range of subjects including multi-agent systems,
game theory, legal reasoning and machine learning (Rah-
wan and Simari 2009). In the medical domain, argumenta-
tion theory has been applied to medical expert systems to
make recommendations with clear reasons supporting them
based on the data given, and whether a given course of treat-
ment is safe to administer (Fox, Glasspool, and Bury 2001;
Fox et al. 2007; Glasspool et al. 2007). CONSULT aims to
able to explain the recommendations it gives in a similar
way, but has the additional ability to reason about patients’
and clinicians’ preferences using EAFs. Further, Hunter and
Williams have proposed argumentation-based techniques to
aggregate the conclusions of various clinical trials to deter-
mine which of two treatments is more effective given the sit-
uation (Hunter and Williams 2010). These techniques can be
useful to CONSULT if we consider incorporating the latest
th1
tl1tls
eh
gl
gd
gh
el
eh   gh
el   gl
(a) Eric’s EAF with his preference arguments
th1
tl1tls
eh
gl
gd
gh
el
gl   el
gh   eh
(b) EAF where GP’s preferences take precedence
Figure 3: EAFs according to the perspectives of Eric and his GP
clinical trials relevant to its various treatment recommenda-
tions.
Atkinson et al. propose an argumentation-based approach
for reasoning with defeasible arguments (Atkinson, Bench-
Capon, and Modgil 2006). To show the applicability of their
approach, they model a DRAMA (Deliberative Reasoning
with Arguments about Actions) agent that would recom-
mend a treatment based on arguments collected from vari-
ous information sources. Similar to CONSULT, they make
use of argument schemes and multiple knowledge bases. In
their model, each argument is associated with values such as
safety and efficacy. Hence, they recommend treatments with
higher values regarding a strict partial ordering on the val-
ues. Our work differs from theirs in that we consider a strict
partial ordering on the arguments and use EAFs for defeasi-
ble reasoning where meta-level attacks are also possible.
Reasoning with arguments that are collected from various
information sources is a challenging problem since each in-
formation source is of varying trustworthiness. The ArgTrust
framework was developed (Tang, Sklar, and Parsons 2012)
and evaluated (Sklar et al. 2016) as a decision-support tool
in which the evidence that influences a recommendation is
modulated according to values of trust that a user places on
the evidence. In their work, they introduce a formal argu-
mentation system for reasoning with the collected informa-
tion. Similar to their work, we would like to associate argu-
ments with trust values depending on the arguments’ sources
of data in order to recommend more reliable treatments.
6 Summary and Future Work
In this paper, we have introduced the argumentation-based
decision support system CONSULT, which aims to assist
healthcare professionals in choosing treatments for their pa-
tients, as well as patients in self-managing their chronic con-
ditions. We have illustrated how CONSULT is designed to
work in the context of treating high blood pressure in recov-
ering stroke patients. We have provided a formal representa-
tion of the NICE guideline CG127 and the NHS Leaflet for
hypertension treatment options. In our proposed approach,
the Treatment Engine instantiates possible treatment argu-
ments given patient information using the ASPT argument
scheme and subjects these to critical questions. As a result
of this step, some arguments are defeated if they do not con-
form with ASPT’s critical questions. Meta-level arguments
are generated from the preferences expressed by the patient
and the GP. An extended argumentation framework (EAF) is
generated from the treatment arguments and the meta-level
preference arguments. The grounded extension of the EAF
is computed by considering different precedences between
the sets of preferences. The presence of a treatment argu-
ment in a grounded extension justifies it as a treatment to
recommend in the given circumstances. We have illustrated
the applicability of our approach through a running example.
In ongoing work, we are implementing and evaluating the
components of the CONSULT architecture outlined here.
The aim is to deploy CONSULT on a mobile device such
as a tablet, with intuitive dashboards for clinicians and pa-
tients. We are planning to evaluate on more complex sce-
narios, through focus groups and user studies. CONSULT
design and features are currently being informed by focus
group interviews consisting of recovering stroke patients
and their carers. In addition to patient facts and patient /
clinician preferences, we will automatically construct argu-
ments from patient data obtained through commercial well-
ness sensors, the patient’s electronic health record, and ex-
tensive clinical guidelines automatically extracted off the
NHS or NICE websites; this will inform personalised treat-
ment plans. Techniques that track data provenance will
be employed to help determine the priority and trustwor-
thiness of such data, and hence the importance of each
argument constructed, which in turn will help determine
which arguments are justified (Modgil and Prakken 2010;
2013). Here, we have considered how CONSULT might
help a patient self-manage one condition, namely high blood
pressure; but in future, argumentation theory will be applied
to resolve conflicting treatments in the case of multiple mor-
bidities and related issues in polypharmacy. Further, patients
and clinicians will be able to understand why such treat-
ments are recommended by CONSULT through the theory
of dialogical argumentation (McBurney and Parsons 2009;
Modgil 2017), where the reasons for a claim can be explic-
itly traced back to its supporting facts and how its counter-
arguments have been defeated.
As CONSULT extracts and aggregates data about each
patient from multiple sources, it will be possible to leverage
this data to benchmark a patient’s additional risks in order
to further personalise treatment. Future work will consider
benchmarking models that may be derived from statistical
models. In order for CONSULT to be able to exploit these
and aggregate all the patient-related conclusions from such
models, we will be exploring if and how arguments can be
derived from the statistical models of the data. Furthermore,
we will explore how these quantitative arguments from the
models can be considered alongside the qualitative argu-
ments such as the ones generated from clinical guidelines,
such as the ones in this paper. This will necessitate further
work in the theory of relating argument schemes and critical
questions to reasoning about preferences between other ar-
guments, and the implementation of argumentation engines
that can reason with preferences and numerical data.
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